Structure Therapeutics Inc. American Depositary Shares (GPCR)
Market Closed
26 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
21. 10
-0.09
-0.4247%
After Hours
$
+2 +9.4787% 23. 10
1.21B Market Cap
- P/E Ratio
- Div Yield
685,627 Volume
- Eps
$ 21.19
Previous Close 
Want to track GPCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results
Structure Therapeutics stock roses sharply Monday after the biotech company delivered "compelling" results for its weight-loss drug.
Investors | 2 years ago
Structure Therapeutics' stock jumps on weight-loss-pill trial results
Structure Therapeutics Inc.'s American depositary receipts GPCR, +1.30% gained more than 6% premarket on Monday after the company said its experimental weight-loss pill achieved its aims in a clinical trial.
Marketwatch | 2 years ago
2026 © Marketlog. All Rights Reserved.
